Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic disease | D002908 | — | — | 2 | 1 | — | — | — | 3 |
Anemia | D000740 | HP_0001903 | D64.9 | 2 | 2 | — | — | — | 3 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.9 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Endotoxemia | D019446 | — | — | 1 | — | — | — | — | 1 |
Inflammation | D007249 | MP_0001845 | — | 1 | — | — | — | — | 1 |
Drug common name | OLAPTESED PEGOL |
INN | olaptesed pegol |
Description | Olaptesed pegol is an unknown pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against stromal cell-derived factor 1. |
Classification | Unknown |
Drug class | aptamers, classical and mirror; PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4594485 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | MTM792B442 (ChemIDplus, GSRS) |